Ethical Issues in Psychosocial Interventions Research Involving Controls

Psychiatric research is of critical importance in improving the care of persons with mental illness. Yet it may also raise difficult ethical issues. This article explores those issues in the context of a particular kind of research: psychosocial intervention research with control groups. We discuss 4 broad categories of ethical issues: consent, confidentiality, boundary violations, and risk-benefit issues. We believe that, despite the potential difficulties, psychosocial intervention research is vital and can be accomplished in an ethical manner. Further discussion and research into these issues are warranted.

[1]  J. Frank,et al.  Psychotherapy and the placebo effect. , 2011, Psychological bulletin.

[2]  L. Walters,et al.  Some Ethical Issues in Research Involving Human Subjects , 2015, Perspectives in biology and medicine.

[3]  R. Slovenko.  Group Psychotherapy: Privileged Communication and Confidentiality , 1977, The Journal of psychiatry & law.

[4]  L. Roth,et al.  Tests of competency to consent to treatment. , 1977, The American journal of psychiatry.

[5]  Lamb Hr,et al.  Supplemental Security Income and the sick role. , 1978 .

[6]  K. O’leary,et al.  Conceptual, methodological, and ethical problems of placebo groups in psychotherapy research. , 1978, The American psychologist.

[7]  K. O’leary,et al.  Conceptual, methodological, and ethical problems of placebo groups in psychotherapy research. , 1978, The American psychologist.

[8]  H. Lamb,et al.  Supplemental Security Income and the sick role. , 1978, The American journal of psychiatry.

[9]  Alan E. Kazdin,et al.  Therapy outcome questions requiring control of credibility and treatment-generated expectancies* , 1979 .

[10]  P. Mcdermott,et al.  Dilemma of the Untreated Control Group in Applied Research: A Proposed Solution , 1981, Psychological reports.

[11]  R. Walls.  Disincentives in Vocational Rehabilitation: Cash and In-Kind Benefits from Other Programs. , 1982 .

[12]  N. Angoff.  An inadvertent breach of confidentiality. , 1984, IRB.

[13]  J. Critelli,et al.  The placebo. Conceptual analysis of a construct in transition. , 1984, The American psychologist.

[14]  R. B. Basham.  Scientific and practical advantages of comparative design in psychotherapy outcome research. , 1986, Journal of consulting and clinical psychology.

[15]  D. Dush.  The Placebo in Psychosocial Outcome Evaluations , 1986 .

[16]  W. Wilkins.  Placebo problems in psychotherapy research. Social-psychological alternatives to chemotherapy concepts. , 1986, The American psychologist.

[17]  M. Parloff.  Placebo controls in psychotherapy research: a sine qua non or a placebo for research problems? , 1986, Journal of consulting and clinical psychology.

[18]  Strayhorn Jm.  Control groups for psychosocial intervention outcome studies. , 1987 .

[19]  J. Strayhorn.  Control groups for psychosocial intervention outcome studies. , 1987, The American journal of psychiatry.

[20]  B. Freedman.  Equipoise and the ethics of clinical research. , 1987, The New England journal of medicine.

[21]  P. Pilkonis,et al.  Conceptual and methodological issues in comparative studies of psychotherapy and pharmacotherapy, I: Active ingredients and mechanisms of change. , 1988, The American journal of psychiatry.

[22]  P. Horváth.  Placebos and common factors in two decades of psychotherapy research. , 1988, Psychological bulletin.

[23]  P. Pilkonis,et al.  Conceptual and methodological issues in comparative studies of psychotherapy and pharmacotherapy, II: Nature and timing of treatment effects. , 1988, The American journal of psychiatry.

[24]  E. Plaut.  The ethics of informed consent: an overview. , 1989, Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Universite d'Ottawa.

[25]  J. Genest,et al.  Clinical research. , 1990, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[26]  G. Klumpner,et al.  On Methods of Reporting Clinical Material , 1991, Journal of the American Psychoanalytic Association.

[27]  R. Lilford,et al.  At what level of collective equipoise does a clinical trial become ethical? , 1991, Journal of medical ethics.

[28]  Green Sw.  Informed consent in therapy. , 1993 .

[29]  D. Rosenhan,et al.  Warning third parties: the ripple effects of Tarasoff. , 1993, Pacific law journal.

[30]  K. Wenning.  Long-term psychotherapy and informed consent. , 1993, Hospital & community psychiatry.

[31]  A. Sugarman.  Victims of abuse : the emotional impact of child and adult trauma , 1994 .

[32]  E. Derenzo.  The ethics of involving psychiatrically impaired persons in research. , 1994, IRB.

[33]  A. Wichman,et al.  Research involving subjects with dementia and other cognitive impairments , 1995, Neurology.

[34]  D. Balk.  Bereavement research using control groups: ethical obligations and questions. , 1995, Death studies.

[35]  R. Levine.  Children as Research Subjects: Ethical and Legal Considerations , 1995 .

[36]  F. Castellanos,et al.  Ethical issues in biological psychiatric research with children and adolescents. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[37]  M. Pearson.  Problems with Transference Interpretations in Short‐Term Dynamic Therapy , 1995 .

[38]  T. Laughren.  Regulatory issues in pediatric psychopharmacology. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[39]  P. Appelbaum,et al.  Constructing competence: formulating standards of legal competence to make medical decisions. , 1996, Rutgers law review.

[40]  L. Glantz.  Conducting research with children: legal and ethical issues. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[41]  R. Dresser.  Mentally disabled research subjects. The enduring policy issues. , 1996, JAMA.

[42]  Bryan Christie,et al.  Creating False Memories , 1997 .

[43]  Jonathan D. Cohen.  Boundaries and Boundary Violations in Psychoanalysis , 1997 .

[44]  Walker Lm.  Guarding patient confidentiality under managed care. , 1997 .

[45]  D. Klein.  Control groups in pharmacotherapy and psychotherapy evaluations. , 1997 .

[46]  A. Aragón,et al.  Participants' understanding of the process of psychological research: informed consent. , 1997, Ethics & behavior.

[47]  C. Schwartz,et al.  The Control Group Dilemma in Clinical Research: Applications for Psychosocial and Behavioral Medicine Trials , 1997, Psychosomatic medicine.

[48]  J. Kane,et al.  The rationale and ethics of medication-free research in schizophrenia. , 1997, Archives of general psychiatry.

[49]  L. Walker.  Guarding patient confidentiality under managed care. , 1997, Medical economics.

[50]  R. Gallop.  Postdischarge Social Contact: A Potential Area for Boundary Violation , 1998 .

[51]  D. Resnik.  The ethics of HIV research in developing nations. , 1998, Bioethics.

[52]  J. Laugharne,et al.  Informed Consent and Antipsychotic Use in Patients with Schizophrenia , 1998 .

[53]  A. Vansteenwegen.  Divorce after couple therapy: an overlooked perspective of outcome research. , 1998, Journal of sex & marital therapy.

[54]  D. Tucker.  Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals , 1998 .

[55]  R. Liberman,et al.  Informed consent: assessment of comprehension. , 1998, The American journal of psychiatry.

[56]  A. Avins,et al.  Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials. , 1998, Journal of medical ethics.

[57]  D. Klein.  Control groups in pharmacotherapy and psychotherapy evaluations. , 1997 .

[58]  J. Tijssen,et al.  Placebos and placebo effects in medicine: historical overview , 1999, Journal of the Royal Society of Medicine.

[59]  C. Weijer.  Placebo-controlled trials in schizophrenia: Are they ethical? Are they necessary? , 1999, Schizophrenia Research.

[60]  R. Ashcroft.  Equipoise, knowledge and ethics in clinical research and practice. , 1999, Bioethics.

[61]  W. Levinson,et al.  Informed decision making in outpatient practice: time to get back to basics. , 1999, JAMA.

[62]  D. Jeste,et al.  Neuroleptic discontinuation in clinical and research settings: scientific issues and ethical dilemmas , 1999, Biological Psychiatry.

[63]  T. Dishion,et al.  When interventions harm. Peer groups and problem behavior. , 1999, The American psychologist.

[64]  L. Lamberg.  False memories, lasting scars. , 1999, JAMA.

[65]  F. Miller.  Placebo-controlled trials in psychiatric research: an ethical perspective , 2000, Biological Psychiatry.

[66]  K. Michels.  The placebo problem remains. , 2000, Archives of general psychiatry.

[67]  D. Jeste,et al.  Enhancing Informed Consent for Research and Treatment , 2001, Neuropsychopharmacology.

[68]  R.,et al.  Competency to Decide on Treatment and Research : MacArthur and Beyond , 2022 .